Vaccine

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan…

11 months ago

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…

11 months ago

Piramal Pharma Limited Announces Results for Q3 and 9M FY25

MUMBAI, India, Jan. 29, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness…

11 months ago

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by nanotechnology focus, AI-driven market transformation – Technavio

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope…

11 months ago

Sonicu awarded Pharmacy Temperature Monitoring agreement with Premier, Inc.

INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ -- Sonicu has been awarded a national group purchasing agreement for Temperature Monitoring with Premier,…

11 months ago

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to…

11 months ago

Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health

Funding expands manufacturing readiness for Valley fever vaccineThis follows Anivive's $33MM NIAID contract for fungal vaccinesIn total, Anivive has secured…

11 months ago

Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement

Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced…

11 months ago

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated…

11 months ago

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 

STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

11 months ago